| Issue Date | Title | Author(s) |
| 2019-09-01 | MicroRNA (miRNA)-to-miRNA Regulation of programmed cell death 4 (PDCD4) | Ajuyah, P; Hill, M; Ahadi, A; Lu, J; Hutvagner, G; Tran, N |
| 2019-09-04 | Heterozygous loss of keratinocyte TRIM16 expression increases melanocytic cell lesions and lymph node metastasis | Sutton, SK; Cheung, BB; Massudi, H; Tan, O; Koach, J; Mayoh, C; Carter, DR; Marshall, GM |
| 2013-09 | BCL-2 hypermethylation is a potential biomarker of sensitivity to antimitotic chemotherapy in endocrine-resistant breast cancer. | Stone, A; Cowley, MJ; Valdes-Mora, F; McCloy, RA; Sergio, CM; Gallego-Ortega, D; Caldon, CE; Ormandy, CJ; Biankin, AV; Gee, JMW; Nicholson, RI; Print, CG; Clark, SJ; Musgrove, EA |
| 2021-04-01 | miRNA interplay: mechanisms and consequences in cancer | Hill, M; Tran, N |
| 2021-03-03 | A novel combination therapy targeting ubiquitin-specific protease 5 in MYCN-driven neuroblastoma | Cheung, BB; Kleynhans, A; Mittra, R; Kim, PY; Holien, JK; Nagy, Z; Ciampa, OC; Seneviratne, JA; Mayoh, C; Raipuria, M; Gadde, S; Massudi, H; Wong, IPL; Tan, O; Gong, A; Suryano, A; Diakiw, SM; Liu, B; Arndt, GM; Liu, T; Kumar, N; Sangfelt, O; Zhu, S; Norris, MD; Haber, M; Carter, DR; Parker, MW; Marshall, GM |
| 2017-04-18 | Clinical relevance of the transcriptional signature regulated by CDC42 in colorectal cancer. | Valdés-Mora, F; Locke, WJ; Bandrés, E; Gallego-Ortega, D; Cejas, P; García-Cabezas, MA; Colino-Sanguino, Y; Feliú, J; Del Pulgar, TG; Lacal, JC |
| 2017-11-07 | Acetylated histone variant H2A.Z is involved in the activation of neo-enhancers in prostate cancer. | Valdés-Mora, F; Gould, CM; Colino-Sanguino, Y; Qu, W; Song, JZ; Taylor, KM; Buske, FA; Statham, AL; Nair, SS; Armstrong, NJ; Kench, JG; Lee, KML; Horvath, LG; Qiu, M; Ilinykh, A; Yeo-Teh, NS; Gallego-Ortega, D; Stirzaker, C; Clark, SJ |
| 2016-07-15 | Single-cell profiling approaches to probing tumor heterogeneity. | Khoo, BL; Chaudhuri, PK; Ramalingam, N; Tan, DSW; Lim, CT; Warkiani, ME |
| 2016-10-11 | MYCN and HDAC5 transcriptionally repress CD9 to trigger invasion and metastasis in neuroblastoma. | Fabian, J; Opitz, D; Althoff, K; Lodrini, M; Hero, B; Volland, R; Beckers, A; de Preter, K; Decock, A; Patil, N; Abba, M; Kopp-Schneider, A; Astrahantseff, K; Wünschel, J; Pfeil, S; Ercu, M; Künkele, A; Hu, J; Thole, T; Schweizer, L; Mechtersheimer, G; Carter, D; Cheung, BB; Popanda, O; von Deimling, A; Koster, J; Versteeg, R; Schwab, M; Marshall, GM; Speleman, F; Erb, U; Zoeller, M; Allgayer, H; Simon, T; Fischer, M; Kulozik, AE; Eggert, A; Witt, O; Schulte, JH; Deubzer, HE |
| 2016-10-11 | MYCN and HDAC5 transcriptionally repress CD9 to trigger invasion and metastasis in neuroblastoma. | Fabian, J; Opitz, D; Althoff, K; Lodrini, M; Hero, B; Volland, R; Beckers, A; de Preter, K; Decock, A; Patil, N; Abba, M; Kopp-Schneider, A; Astrahantseff, K; Wünschel, J; Pfeil, S; Ercu, M; Künkele, A; Hu, J; Thole, T; Schweizer, L; Mechtersheimer, G; Carter, D; Cheung, BB; Popanda, O; von Deimling, A; Koster, J; Versteeg, R; Schwab, M; Marshall, GM; Speleman, F; Erb, U; Zoeller, M; Allgayer, H; Simon, T; Fischer, M; Kulozik, AE; Eggert, A; Witt, O; Schulte, JH; Deubzer, HE |
